FDA NDC Directory · JSON-LD · Markdown

Imbruvica

NDC 57962-007 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameIbrutinib
Labeler / ManufacturerPharmacyclics LLC
Marketing categoryNew Drug Application (innovator) · App NDA217003
Dosage form / routeSUSPENSION · ORAL
Active ingredientsIBRUTINIB (70 mg/mL)
Marketing started20220824
Package count1

External sources

Source: openFDA. Public-domain (CC0).